1. Mentors-in-Residence (MIR): Industry experts with 10 or more years of experience in commercialization of early stage life science innovation. The MIR is matched to a Rutgers faculty to help prepare a funding application, with an emphasis on commercialization. Each assignment lasts about 45 days and the MIR receives a payment of $2,500 per complete application submitted.
2. Reviewers: Industry experts with 10 or more years of technical expertise in an area of life sciences, with a strong focus on commercial product development. A reviewer is assigned to review HealthAdvance Applications per program guidelines and provide a detailed evaluation. Each review usually takes 3-4 hours. The reviewer receives an honorarium of $250 per submitted evaluation.
Suitable candidates can serve as both MIRs and reviewers, obviously not for the same application.
The HealthAdvance team operates out of Rutgers, Office of Research and Economic Development's Research Commercialization unit, with a goal of advancing the university's biomedical technologies to the market. If you are interested in either or both roles, please click on the link below or scan the QR codes with your mobile device.
For details: https://rutgers.ca1.qualtrics.com/jfe/form/SV_9KXahH2VuXVauvr